ClinicalTrials.gg
RecruitingNCT07370311Updated Nov 4, 2026

A Culturally Adapted Decision Aid Intervention to Support Chinese American Dementia Caregivers in Feeding-Related Decisions

An interventional study of Chinese version of Making Choices Feeding Options for Patients with Dementia Decision Aid in Dementia Caregivers, End of Life Decision Making and Advanced Dementia, sponsored by Yaolin Pei. Recruiting at 1 site in United States. Open to participants aged 21 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Yaolin Pei · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 7 months later.
Updated Nov 4, 2026Primary completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
21 Years to 99 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 118 studies in Death with a site in United States — 13 open to participants now, 27 under way, 1 of them phase 3. Death · United States.

Planned enrollment
60th of 79
60 · median 154
Started
2026
with 4 others
No phase
68 of 118
9 open now
Primary completion
2027-07
later than 15 of 26 live
Registered
115th of 118
by date

Among the 118 studies in Death with a site in United States, this one is the 60th largest by planned enrollment of the 79 interventional ones that give a count, is one of 5 that started in 2026, is one of 68 with no phase, reaches primary completion later than 15 of the 26 other live ones, and was the 115th registered.

Death

457 studies on the registry are indexed under Death; 85 are open to participants now.

Browse Death studies →

Open to participants now

13 of the 118 studies in Death with a site in United States are open now. Recruiting first, the newest first:

7 more — sign in →

All 13 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 58 Death studies recruiting now, 43 (74%) set no upper age limit and 8 (14%) stop at 75 or younger; 11 take children under 18; 14 take healthy volunteers.

This study: 21 Years to 99 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 118 studies in Death with a site in United States, or all of them as a file.
02

Study summary

Family caregivers of people with dementia have to decide between tube feeding and hand feeding when persistent eating problems arise. This decision can be difficult for Chinese American dementia caregivers, due to the interplay of culture, potential absence of a patient's advance directive, poor understanding of dementia, and lack of knowledge on the risks and benefits of tube feeding. In this polit study, the principal investigator examines whether a culturally adapted decision aid intervention regarding feeding options named "Chinese version of Making Choices Feeding Options for Patients with Dementia Decision Aid" (CMCFODA) will improve Chinese American caregivers' decision-making about feeding options in patients with moderate or advanced dementia. The proposed study advances the field by providing critical evidence to inform the development and implementation of culturally adapted decision support interventions in end-of-life dementia care.

03

Conditions studied

  • Dementia Caregivers
  • End of Life Decision Making
  • Advanced Dementia

Browse trials for

Keywords

  • Chinese Americans
  • feeding options
  • decision aid
  • decision coaching
04

Who can participate

Ages eligible
21 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 21 years and older
  • Self-identify as Chinese
  • Providing caregiving or involvement in end-of-life care decision-making for older Chinese adults with: a) moderate or advanced dementia, b) feeding difficulties, and c) poor oral intake, eating/swallowing problems, or weight loss

Exclusion criteria

Exclusion Criteria:

  • Dementia patients are a) receiving tube feeding, b) enrolled in hospice care, or 3) have a documented preference against a feeding tube
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    Participation Group

    1. Receive usual care (including information from healthcare providers) 2. Receive electrical version of decision aid after all of the data collection

  • Experimental
    Intervention/Treatment Group

    1. Receive both the electronic and paper version of CMCFODA 2. Receive an individualized decision coaching within two weeks

    Other: Chinese version of Making Choices Feeding Options for Patients with Dementia Decision Aid

Interventions

  • OtherChinese version of Making Choices Feeding Options for Patients with Dementia Decision Aid

    Participants in the treatment group will receive the CMCFODA via zoom meeting or another secure video conferencing platform and an individualized decision coaching.

06

What researchers measure

Primary outcomes

  1. Decision conflict

    SURE test for decisional conflict (0-4)

    Time frame: Baseline; One-Month Follow-Up; Three-Month Follow-Up

  2. Knowledge of feeding options and dementia

    Questions to assess knowledge about feeding options and dementia

    Time frame: Baseline; One-Month Follow-Up; Three-Month Follow-Up

  3. Expectations of tube feeding

    Questions about understanding differing expectations regarding feeding tube use

    Time frame: Baseline; One-Month Follow-Up; Three-Month Follow-Up

Secondary outcomes

  1. Frequency of communication with other family members and healthcare providers

    Questions to understand caregiver involvement, support, and information flow

    Time frame: Baseline; One-Month Follow-Up; Three-Month Follow-Up

  2. Preference of feeding option

    Careful hand feeding, tube feeding, or unsure

    Time frame: Baseline; One-Month Follow-Up; Three-Month Follow-Up

  3. Preparation for decision-making scale (treatment group only)

    Questions to assess the effect of the intervention by preparing for feeding option decision-making

    Time frame: One-Month Follow-Up; Three-Month Follow-Up

  4. The Feasibility of the CMCFODA study as measured by recruitment rates and the proportion of participants that decline participation.

    The feasibility of the CMCFODA study will be measured by the proportion of eligible participants who decline to participate among those who were screened into the study.

    Time frame: Enrollment

  5. The Feasibility of the CMCFODA study as measured by participant retention, as indicated by the number of participants lost to follow-up.

    Participant retention, as an aspect of feasibility, will be measured by the recorded number of participants number lost to follow-up.

    Time frame: Enrollment, One-Month Follow-Up,Three-Month Follow-Up

  6. Acceptability of the decision aid and decision coaching (only for the treatment group)

    We will use developed questions to measure the acceptability of this intervention

    Time frame: One Month Follow-Up

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Data collected for the CMCFODA study will be shared only after the investigators have published findings addressing the study's specific aims. Intellectual property and data generated under this project will be managed in accordance with University of Texas at Austin and NIH policies, including the NIH Data Sharing Policy and Implementation Guidance. Following publication of the investigators' primary findings, access to the study databases and associated decision aid intervention tools will be made available for educational, research, and non-profit purposes.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

Time frame: These data will be shared after the investigators have published the study's specific aims. Requests to access the code for this study will be reviewed by the investigative team and granted once feasibility, acceptability, and preliminary efficacy have been evaluated and the findings have been published.

Access criteria: Individuals who wish to access the data must agree to: (1) use the data solely for research purposes; (2) not attempt to identify any individual participant; (3) securely store the data using appropriate safeguards, such as password-protected servers and files; and (4) return and/or destroy the data upon completion of analyses.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Jul 2027, 16 months after the start.

Of 107 non-industry interventional studies with no phase under Death, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 48. This study's planned 16 months is below that.

Counting every sponsor, half of 111 studies reached it within 23 months; a quarter within 13 and three quarters within 48.

Primary completion moved once since we started tracking on Sep 25, 2026: Jun 2027 → Jul 2027, on Nov 4, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 22, 2026
First posted
Jan 27, 2026
StartActual
Mar 24, 2026
Primary completionEst.
Jul 31, 2027was Jun 2027
CompletionEst.
Jul 31, 2028
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jun 30, 2027→Jul 31, 2027
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Primary completion Jun 30, 2027→Jul 31, 2027

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07370311
Lead sponsor
Yaolin Pei
Responsible party
Yaolin Pei (PhD, University of Texas at Austin) — Sponsor-investigator
First posted
Jan 27, 2026
Start date
Mar 24, 2026
Primary completion
Jul 31, 2027 (estimated)
Completion
Jul 31, 2028 (estimated)
Last update
Nov 4, 2026

Study contacts

Yaolin Pei, Ph.D.
Contact
yaolin.pei@austin.utexas.edu
8064708689

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion